[Bioc-devel] package review help

Vincent Carey stvjc at channing.harvard.edu
Sat Oct 1 03:53:23 CEST 2016

i would have comments on StarTrek.  if you would like me to be reviewer of
that i can do it.

a query on policy

how do you propose to handle needlessly repeated code?

the code given below is repeated many many times with slight variations for
selected KEGG_path.  i would ask the author
to implement DRY (don't repeat yourself), find a functional approach to the
repeated element, and
simplify.  i can imagine that damping enthusiasm of the contributor but I
think it is worth holding back
until such a thing is accomplished.  too meddlesome?

if (KEGG_path=="Carb_met") {
pathways.list <- keggList("pathway", "hsa")## returns the list of human
for (i in 1:length(pathways.list)){
if (length(intersect(pathways.list[[i]],common)!=0)){
pathway.codes <- sub("path:", "", names(pathways.list))
a<-do.call("rbind", pathways.list)

Another issue the author seems to raise is the need for "open cytoscape
session" for meaningful tests.
I think this will never happen on the build system.  So the author has to
emulate the cytoscape behavior
perhaps with some static objects that cytoscape might return on interaction.

On Fri, Sep 30, 2016 at 5:22 PM, Martin Morgan <
martin.morgan at roswellpark.org> wrote:

> On 09/30/2016 12:05 PM, Michael Lawrence wrote:
>> I have been chipping in here and there, but I'm not sure if I'm
>> causing more confusion than help. I just select packages that interest
>> me and contribute bite size pieces, but I would be happy to assume a
>> more formal role. It takes very little of my time.
>> One suggestion is that reviews should be incremental, i.e., provide
>> obvious feedback first, let the package authors respond, then dig
>> deeper for more detailed comments.
> Michael, I've found your comments / reviews really helpful. They are
> generally on-target and constructive, and help spur the authors to think
> about what they are doing. They do in some ways 'confuse' the issue (how is
> the package author to know that the 'assignee' is the official reviewer?
> are the people commenting on the package providing a consistent message?),
> but definitely a plus. I encourage others to participate in the public
> review process in this way, too.
> It would be great to hear from people who would like to take on the role
> of assigned reviewer. I'd suggest you identify package(s) that would be
> interesting to you, and send email to me. I'll arrange for you to become
> the assigned reviewer, and provide basic instructions and guidelines. In
> the future, you will be able to take on a package more directly.
> From the formal review process, incremental additional comments are not a
> good way to go, because the package author can feel like they are on a
> never-ending treadmill of requirements. Instead I think the formal review
> should more or less set out a contract -- do these things and your package
> will meet reviewer requirements for inclusion in Bioconductor. This makes
> it harder / more time consuming to review the package, because there is
> only the one chance to identify the most important points. Also, one needs
> to follow through and confirm that yes, the appropriate changes were made.
> It will be interesting to adjust the public review process, especially
> after the next release. For instance, one approach I like is to provide a
> review with editable check boxes, with the package author editing the
> review with information about commits, etc, that satisfy the concerns being
> expressed. I don't really like the canned check-list in the joss link Tim
> mentions; they point to important areas but seem too generic to lead to
> constructive changes to individual packages.
> Martin
>> Michael
>> On Fri, Sep 30, 2016 at 8:49 AM, Kasper Daniel Hansen
>> <kasperdanielhansen at gmail.com> wrote:
>>> One of the advantages of the Github review process is open review.  We
>>> have
>>> some amount of packages submitted in the last moment (and I am guilty of
>>> one of these).  Is help with the reviews needed?  If so, how do we know
>>> where to concentrate?
>>> Kasper
>>>         [[alternative HTML version deleted]]
>>> _______________________________________________
>>> Bioc-devel at r-project.org mailing list
>>> https://stat.ethz.ch/mailman/listinfo/bioc-devel
>> _______________________________________________
>> Bioc-devel at r-project.org mailing list
>> https://stat.ethz.ch/mailman/listinfo/bioc-devel
> This email message may contain legally privileged and/or...{{dropped:2}}
> _______________________________________________
> Bioc-devel at r-project.org mailing list
> https://stat.ethz.ch/mailman/listinfo/bioc-devel


Vincent J. Carey, Ph.D.
Professor of Medicine
Channing Division of Network Medicine
Brigham and Women's Hospital
Harvard Medical School
181 Longwood Avenue
Boston, MA 02115 USA

	[[alternative HTML version deleted]]

More information about the Bioc-devel mailing list